The American Journal of Managed Care20 天
Muscle-Directed Therapy Apitegromab Meets Primary End Point in Phase 3 SAPPHIRE Trial of SMA
Phase 2 TOPAZ trial data support apitegromab's potential ... A total of 11 patients in the population had scoliosis surgery during the study and their data was excluded from any HFMSE or RULM ...
SMA28 天
Apitegromab hits goal of boosting motor function in Phase 3 trial
These data align with improvements in motor function seen for up to four years in the earlier Phase 2 TOPAZ study (NCT03921528), supporting the company’s plans to file for approval in the U.S. and the ...